Skip to content

A Study of Prognosis in Late-Stage Parkinson's Disease in Japan

A Japanese Multicenter Prospective Study of Prognosis in Late-Stage Parkinson's Disease (a National Hospital Organization Network collaborative study) - A Japanese Prospective Study of Prognosis in Late-Stage Parkinson's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053949
Enrollment
500
Registered
2024-03-31
Start date
2024-04-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Sponsors

National Hospital Organization Higashinagoya National Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who met all of the following criteria were enrolled : 1) Patients diagnosed with clinically-established PD according to the International Parkinson and Movement Disorder Society (MDS) criteria 2) Patients who had been diagnosed with PD for at least 7 years 3) Patients with "Hoehn and Yahr stage IV or V" or "less than 50% on the Schwab and England scale" at the time of admission 4) Patients who were managed as outpatients for PD treatment or hospitalized within 14 days 5) Patients with a caregiver able to cooperate with the survey and who can objectively assess the patient if the patient is homebound 6) Patients whose condition has been stable for the past 14 days 7) Patients who provided written consent for inclusion in this study by the patient or a surrogate

Exclusion criteria

Exclusion criteria: Patients who fall under any of the following categories were excluded: 1) Patients admitted for treatment of complications 2) Patients transferred from an acute care hospital 3) Patients judged by the principal investigator or research coordinator to be inappropriate for participation in this study

Design outcomes

Primary

MeasureTime frame
Changes in the MDS-UPDRS, Hoehn and Yahr stage, and Schwab and England ADL scale from baseline to 18 months

Secondary

MeasureTime frame
1) Baseline Motor function, Cognitive function, Nutritional status, Treatment, Quality of life of the patient/family, use of long-term care insurance, level of care required, care burden, utilization of social resources, Frequency of falls, history of fractures 2) Prognosis Survival/death, pneumonia, fractures, complications requiring hospitalization (excluding pneumonia and fractures), institutionalization (first time only), cognitive function, quality of life, burden of care, changes in care setting during 18 months.

Countries

Japan

Contacts

Public ContactIkuko Aiba

National Hospital Organization Higashinagoya National Hospital Department of Neurology

ikukoaiba0401@gmail.com052-801-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026